The Study Committee on Cancer Care Access convened on May 29, 2025, to discuss critical issues surrounding cancer treatment accessibility in Georgia. The meeting highlighted the importance of addressing pharmacy benefit manager (PBM) practices and their impact on healthcare costs.

A key focus of the discussion was an executive order issued by the President on April 15, 2025. This order aims to tackle several issues related to PBMs, particularly in sections 8, 9, 10, and 12, which address transparency in PBM fee disclosures and anti-competitive behaviors. Section 11 specifically directs the Secretary of Health and Human Services to prevent Medicare from shifting drug administration from more affordable physician office settings to pricier hospital outpatient departments.

The committee emphasized the significance of these developments for community oncology practices, noting that they could lead to improved access to high-quality, low-cost cancer care. Members expressed optimism that state-level actions could complement federal initiatives, ensuring that patients receive necessary treatments close to home.

The meeting concluded with gratitude expressed towards the committee members for their efforts in addressing these pressing healthcare concerns. The discussions underscored a collaborative approach to enhancing cancer care access in Georgia, with a focus on maintaining affordability and quality for patients.